NFKB1 and Alzheimer disease: When comparisons were made between the human and mouse DAM response irrespective of TREM2, the top five upregulated pathways in the human AD brain included chemotaxis, IL-6, and NF-κB, corresponding to the readout from the CHRFAM7A-carrier iPSC model.